| 翻訳と辞書 |
| Triple releasing agent ： ウィキペディア英語版 |
Serotonin-norepinephrine-dopamine releasing agent
A serotonin-norepinephrine-dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug which induces the release of serotonin, norepinephrine (and epinephrine), and dopamine in the body and/or brain.
Examples of SNDRAs include certain amphetamines (e.g., MDMA, MDA, 4-methylamphetamine, 6-APB, naphthylisopropylamine), cathinones (e.g., mephedrone, methylone), tryptamines (e.g., αMT, αET), and agents of other chemical classes (e.g., 4,4'-DMAR, 5-IAI).〔Bruce E. Blough, Richard Rothman, Antonio Landavazo, Kevin M. Page, Ann Marie Decker. Phenylmorpholines and analogues thereof. US Patent 2013/0203752〕 These drugs possess euphoriant, entactogen, and stimulant effects, and are almost exclusively encountered as drugs of abuse. Most are also neurotoxic to serotonergic and/or dopaminergic neurons.
==See also==
* Monoamine releasing agent
* Serotonin-norepinephrine-dopamine reuptake inhibitor
* Serotonin-dopamine releasing agent
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Serotonin-norepinephrine-dopamine releasing agent」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|